Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A special gel with medicine helps prevent melanoma from coming back after surgery.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

A man developed an allergic skin reaction after using brimonidine for rosacea.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Early diagnosis and treatment of Kaposi varicelliform eruption are crucial to prevent severe complications.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Sintilimab treatment caused hair loss but led to complete tumor remission.

The woman's widespread skin condition did not improve despite various treatments.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib improved hair loss and arthritis in a lupus patient.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

The FDA did not approve a testosterone drug because of safety concerns.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

The adapalene-benzoyl peroxide gel works better and faster for acne treatment than using either ingredient alone, with manageable side effects.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.